176 related articles for article (PubMed ID: 33494357)
1. Real-World Data and Machine Learning to Predict Cardiac Amyloidosis.
García-García E; González-Romero GM; Martín-Pérez EM; Zapata Cornejo ED; Escobar-Aguilar G; Cárdenas Bonnet MF
Int J Environ Res Public Health; 2021 Jan; 18(3):. PubMed ID: 33494357
[TBL] [Abstract][Full Text] [Related]
2. Amyloid transthyretin cardiac amyloidosis: diagnosis and management.
Di Giovanni B; Gustafson D; Delgado DH
Expert Rev Cardiovasc Ther; 2019 Sep; 17(9):673-681. PubMed ID: 31478389
[No Abstract] [Full Text] [Related]
3. Diagnostic approach to cardiac amyloidosis.
Amin HZ; Mori S; Sasaki N; Hirata K
Kobe J Med Sci; 2014 Jun; 60(1):E5-E11. PubMed ID: 25011639
[TBL] [Abstract][Full Text] [Related]
4. Abrupt Onset of Refractory Heart Failure Associated With Light-Chain Amyloidosis in Hypertrophic Cardiomyopathy.
Tomberli B; Cappelli F; Perfetto F; Olivotto I
JAMA Cardiol; 2017 Jan; 2(1):94-97. PubMed ID: 27806176
[TBL] [Abstract][Full Text] [Related]
5. A novel risk score to predict survival in advanced heart failure due to cardiac amyloidosis.
Kreusser MM; Volz MJ; Knop B; Ehlermann P; Schmack B; Ruhparwar A; Hegenbart U; Schönland SO; Katus HA; Raake PW
Clin Res Cardiol; 2020 Jun; 109(6):700-713. PubMed ID: 31630214
[TBL] [Abstract][Full Text] [Related]
6. Cardiac amyloidosis: an approach to diagnosis and management.
Halwani O; Delgado DH
Expert Rev Cardiovasc Ther; 2010 Jul; 8(7):1007-13. PubMed ID: 20602561
[TBL] [Abstract][Full Text] [Related]
7. Current state of cardiac amyloidosis.
Sharma N; Howlett J
Curr Opin Cardiol; 2013 Mar; 28(2):242-8. PubMed ID: 23324855
[TBL] [Abstract][Full Text] [Related]
8. [Chronic heart failure in patients with cardiac amyloidosis].
Solomakhina NI; Varshavskiĭ VA; Gundarova LV; Golitsina EP; Shchekochikhin DIu
Klin Med (Mosk); 2009; 87(3):26-30. PubMed ID: 19469251
[TBL] [Abstract][Full Text] [Related]
9. Predictors of in-hospital length of stay among cardiac patients: A machine learning approach.
Daghistani TA; Elshawi R; Sakr S; Ahmed AM; Al-Thwayee A; Al-Mallah MH
Int J Cardiol; 2019 Aug; 288():140-147. PubMed ID: 30685103
[TBL] [Abstract][Full Text] [Related]
10. [The rapid progress of heart failure due to systemic amyloidosis with cardiac involvement--case report].
Gilowski W; Stryjewski P; Gilowska M; Liszniański P; Nowak J
Przegl Lek; 2015; 72(11):697-700. PubMed ID: 27012134
[TBL] [Abstract][Full Text] [Related]
11. Validating a Machine Learning Algorithm to Predict 30-Day Re-Admissions in Patients With Heart Failure: Protocol for a Prospective Cohort Study.
Kakarmath S; Golas S; Felsted J; Kvedar J; Jethwani K; Agboola S
JMIR Res Protoc; 2018 Sep; 7(9):e176. PubMed ID: 30181113
[TBL] [Abstract][Full Text] [Related]
12. Prediction of myopia development among Chinese school-aged children using refraction data from electronic medical records: A retrospective, multicentre machine learning study.
Lin H; Long E; Ding X; Diao H; Chen Z; Liu R; Huang J; Cai J; Xu S; Zhang X; Wang D; Chen K; Yu T; Wu D; Zhao X; Liu Z; Wu X; Jiang Y; Yang X; Cui D; Liu W; Zheng Y; Luo L; Wang H; Chan CC; Morgan IG; He M; Liu Y
PLoS Med; 2018 Nov; 15(11):e1002674. PubMed ID: 30399150
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy.
Vogelsberg H; Mahrholdt H; Deluigi CC; Yilmaz A; Kispert EM; Greulich S; Klingel K; Kandolf R; Sechtem U
J Am Coll Cardiol; 2008 Mar; 51(10):1022-30. PubMed ID: 18325442
[TBL] [Abstract][Full Text] [Related]
14. Artificial plant optimization algorithm to detect heart rate & presence of heart disease using machine learning.
Sharma P; Choudhary K; Gupta K; Chawla R; Gupta D; Sharma A
Artif Intell Med; 2020 Jan; 102():101752. PubMed ID: 31980091
[TBL] [Abstract][Full Text] [Related]
15. Cardiac Amyloidosis: An Updated Review With Emphasis on Diagnosis and Future Directions.
Bhogal S; Ladia V; Sitwala P; Cook E; Bajaj K; Ramu V; Lavie CJ; Paul TK
Curr Probl Cardiol; 2018 Jan; 43(1):10-34. PubMed ID: 29173805
[TBL] [Abstract][Full Text] [Related]
16. Extracorporeal membrane oxygenation as bridge-to-decision in acute heart failure due to systemic light-chain amyloidosis.
Mancio Silva J; Fontes-Carvalho R; Valente D; Almeida C; Cruz AJ; Tente D; Coelho H; Oliveira M; Albuquerque A; Ribeiro VG
Am J Case Rep; 2015 Mar; 16():174-81. PubMed ID: 25803181
[TBL] [Abstract][Full Text] [Related]
17. Modelling disease risk for amyloid A (AA) amyloidosis in non-human primates using machine learning.
Leung ET; Raboin MJ; McKelvey J; Graham A; Lewis A; Prongay K; Cohen AM; Vinson A
Amyloid; 2019 Sep; 26(3):139-147. PubMed ID: 31210531
[No Abstract] [Full Text] [Related]
18. Amyloid Light-Chain Amyloidosis Manifesting as Heart Failure with Preserved Ejection Fraction in a Patient with Hyper-Immunoglobulin E-emia.
Nojima Y; Ihara M; Kurimoto T; Nanto S
Am J Case Rep; 2016 Apr; 17():235-40. PubMed ID: 27064109
[TBL] [Abstract][Full Text] [Related]
19. Systemic light-chain amyloidosis presenting with rapid progressive heart failure.
Sunbul M; Durmus E; Kivrak T; Besiroglu F; Gerin F; Sari I; Mutlu B
Ther Adv Cardiovasc Dis; 2013 Aug; 7(4):224-7. PubMed ID: 23868674
[TBL] [Abstract][Full Text] [Related]
20. An interesting case of cardiac amyloidosis initially diagnosed as hypertrophic cardiomyopathy.
Boufidou A; Mantziari L; Paraskevaidis S; Karvounis H; Nenopoulou E; Manthou ME; Styliadis IH; Parcharidis G
Hellenic J Cardiol; 2010; 51(6):552-7. PubMed ID: 21169191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
